In a filing, Syros Pharmaceuticals Inc revealed its Director Fanucci Marsha acquired Company’s shares for reported $924.0 on Mar 14 ’25. In the deal valued at $0.10 per share,9,333 shares were bought.
Then, WIRTH PETER bought 9,333 shares, generating $2,008 in total proceeds.
Before that, Flagship Pioneering Fund VII, bought 1,135,308 shares. Syros Pharmaceuticals Inc shares valued at $272,474 were divested by the Affiliate at a price of $0.24 per share.
H.C. Wainwright upgraded its Syros Pharmaceuticals Inc [SYRS] rating to a Buy from a a Neutral in a research note published on November 04, 2020; the price target was increased to $15 from $11. A number of analysts have revised their coverage, including Alliance Global Partners’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Wedbush also remained covering SYRS and has decreased its forecast on January 17, 2020 with a “Neutral” recommendation from previously “an Outperform” rating.
Price Performance Review of SYRS
On Friday, Syros Pharmaceuticals Inc [NASDAQ:SYRS] saw its stock jump 20.78% to $0.09. Over the last five days, the stock has gained 12.82%. Syros Pharmaceuticals Inc shares have fallen nearly -59.79% since the year began. Nevertheless, the stocks have fallen -98.57% over the past one year. While a 52-week high of $6.93 was reached on 03/11/25, a 52-week low of $0.07 was recorded on 03/04/25. SMA at 50 days reached $0.1733, while 200 days put it at $2.1955.
Levels Of Support And Resistance For SYRS Stock
The 24-hour chart illustrates a support level at 0.0701, which if violated will result in even more drops to 0.0478. On the upside, there is a resistance level at 0.1211. A further resistance level may holdings at 0.1498. The Relative Strength Index (RSI) on the 14-day chart is 38.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0227, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.30%. Stochastics %K at 8.23% indicates the stock is a buying.
How much short interest is there in Syros Pharmaceuticals Inc?
A steep rise in short interest was recorded in Syros Pharmaceuticals Inc stocks on 2025-02-28, growing by 0.22 million shares to a total of 0.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 0.72 million shares. There was a rise of 23.03%, which implies that there is a positive sentiment for the stock.
